Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease

Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease

BackgroundWhether fibroblast growth factor 23 (FGF23) directly induces left ventricular hypertrophy (LVH) remains controversial. Recent studies showed an association between FGF23 and the renin-angiotensin-aldosterone system (RAAS). The aim of this study was to investigate changes in FGF23 levels an...

Full description

Bibliographic Details
Main Authors: Kentaro Watanabe, Hideki Fujii, Kohei Okamoto, Keiji Kono, Shunsuke Goto, Shinichi Nishi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
fibroblast growth factor 23
renin-angiotensin-aldosterone system
left ventricular hypertrophy (LVH)
aldosterone (Ald)
angiotensin-converting enzyme 2 (ACE2)
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1276664/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1276664/full

Similar Items